Use of c7E3 Fab in conjunction with prim
โ
Schultz, Richard D. ;Heuser, Richard R. ;Hatler, Carol ;Frey, Dianne
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 705 KB
Although use of thrombolytic therapy during primary angioplasty is controversial, the development of a monoclonal antibody (c7E3 Fab) to the platelet glycoprotein llblllla receptor has been a tremendous breakthrough in the field of interventional cardiology. Use of the antibody during high-risk angi